Location: Home
  • search
  • go
  • Relate News
  • 4/15/2024China Biopharma Tracker – Q1 2024 (PharmaDJ)
  • 4/3/2024Chinese ADC Investment Boom in Question With China-U.S. R&D Relations ...
  • 4/3/2024Genmab A/S to Acquire ADC Developer ProfoundBio for $1.8B Cash
  • 4/1/2024NMPA Announces Package Insert Revision of Metronidazole Injection and ...
  • 3/26/2024NMPA Publishes the 2023 Annual Report for Adverse Drug Reaction Monito...
  • 3/25/2024Chinese ADC Developers Unveil More Target Combos In Bispecific Drive (...
  • 3/22/2024NMPA Announces Package Insert Revision of Multiple Drugs
  • 3/20/2024WuXi XDC Builds Singapore Manufacturing Facility for Global Bioconjuga...
  • 3/10/2024China Biopharma Tracker – February 2024 (PharmaNJ)
  • 3/5/2024China Biopharma Tracker – January 2024 (PharmaNJ)
  • 2/22/2024New Trade Patterns in 2023: Cars, Chemicals, and China (AEI)
  • 2/19/2024Gilead and Biocytogen Strike a Multi-Target Antibody Collaboration Dea...
  • 2/19/2024Trends in the Disease Burden of Anxiety Disorders in Middle-Aged and O...
  • 2/7/2024Review and Outlook of China's Foreign Trade of Medicines and Health Pr...
  • 2/6/2024 Luye Pharma Collaborates with Myung In Pharm in Advancing Treatment f...
  • 1/29/2024China's Pivotal Role in Advancing ADCs Draws Attention of Pharma Giant...
  • 1/25/2024Celltrion, China's WuXi Bolster Ties on ADC Partnership
  • 1/18/2024China Biopharma Tracker 2023 (PharmaDJ)
  • 1/11/2024Biocytogen Enters into Bispecific Antibody Drug Conjugate Agreement wi...
  • 1/9/2024Biogen, Eisai Granted Chinese Approval of Their Alzheimer's Drug Leqem...
  • 12/27/2023vTv Therapeutics Received Notice from Huadong Pharma for Termination o...
  • 12/27/2023Innovent and Xuanzhu Enter into Clinical Trial Collaboration for Combo...
  • 12/25/2023InxMed Enters License Agreement with Escugen to Develop Next-Generatio...
  • 12/25/2023Biocytogen Enters into Antibody Deal with Ona Therapeutics to Develop ...
  • 12/20/2023Huadong to Buy China Rights to Impact's Cancer Drug for $41M
  • 12/18/2023Pfizer/Seagen Pick Up HBM/NonaBio's ADC HBM9033 in $1B License Deal
  • 12/15/2023China Biopharma Tracker – Novermber 2023 (PharmaDJ)
  • 12/12/2023BMS and SystImmune Announce a Global Strategic Deal for ADC BL-B01D1
  • 11/23/2023Myricx Concludes Global Licence Deal for WuXi Bio's Antibody
  • 11/23/2023PharmaDJ's China Biopharma Tracker – October 2023 (PharmaDJ)
  • Page:1/25 Total number of articles:747: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group